Return to Home Incidence > Table

Incidence Rates Table

Data Options
Comparison Options

Incidence Rate Report by State

Stomach (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 3.5 (3.5, 3.5) N/A 14,088 54.0
New York 7 4.4 (4.3, 4.5) 1 (1, 3) 1,109 52.7
Alaska 2 4.4 (3.7, 5.1) 2 (1, 20) 34 62.9
California 7 4.3 (4.2, 4.4) 3 (1, 4) 1,909 56.1
Illinois 7 4.0 (3.8, 4.1) 4 (3, 9) 616 56.6
Hawaii 7 3.9 (3.5, 4.4) 5 (1, 21) 78 51.4
Mississippi 2 3.9 (3.6, 4.2) 6 (2, 17) 141 55.3
Connecticut 7 3.8 (3.6, 4.1) 7 (3, 17) 183 53.0
New Jersey 7 3.8 (3.6, 3.9) 8 (4, 15) 435 49.0
Louisiana 7 3.7 (3.5, 3.9) 9 (4, 20) 209 52.4
Texas 7 3.7 (3.6, 3.8) 10 (6, 15) 1,111 53.7
Delaware 2 3.6 (3.2, 4.2) 11 (2, 38) 47 55.3
Rhode Island 2 3.6 (3.2, 4.1) 12 (2, 36) 51 54.1
Georgia 7 3.6 (3.5, 3.8) 13 (6, 20) 437 52.2
Wisconsin 2 3.6 (3.4, 3.8) 14 (6, 23) 272 58.8
Maryland 2 3.5 (3.3, 3.7) 15 (6, 25) 266 50.9
Pennsylvania 2 3.4 (3.3, 3.6) 16 (11, 24) 599 56.9
District of Columbia 2 3.4 (2.8, 4.1) 17 (2, 50) 23 47.7
Massachusetts 2 3.4 (3.2, 3.6) 18 (10, 29) 302 54.1
North Carolina 2 3.4 (3.2, 3.5) 19 (12, 28) 431 53.6
South Carolina 2 3.3 (3.1, 3.5) 20 (11, 34) 221 53.9
Michigan 2 3.3 (3.1, 3.4) 21 (14, 33) 431 53.8
Missouri 2 3.3 (3.1, 3.4) 22 (13, 35) 253 57.4
Kentucky 7 3.2 (3.0, 3.5) 23 (13, 38) 181 50.3
Washington 1 3.2 (3.0, 3.4) 24 (15, 37) 292 54.8
Florida 2 3.2 (3.1, 3.3) 25 (19, 34) 981 53.0
Maine 2 3.1 (2.8, 3.5) 26 (9, 49) 64 51.8
Vermont 2 3.1 (2.6, 3.7) 27 (4, 51) 28 57.1
Ohio 2 3.1 (3.0, 3.2) 28 (20, 39) 465 54.1
New Mexico 7 3.1 (2.8, 3.4) 29 (13, 48) 83 48.2
Minnesota 2 3.1 (2.9, 3.3) 30 (17, 43) 216 52.8
Indiana 2 3.1 (2.9, 3.2) 31 (19, 43) 253 55.1
Arkansas 2 3.1 (2.8, 3.3) 32 (16, 47) 115 50.7
Kansas 2 3.0 (2.8, 3.3) 33 (16, 48) 107 55.7
Virginia 2 3.0 (2.9, 3.2) 34 (22, 45) 309 52.8
Nebraska 2 2.9 (2.6, 3.3) 35 (15, 50) 68 57.9
Oklahoma 2 2.9 (2.7, 3.2) 36 (21, 49) 136 53.9
New Hampshire 2 2.9 (2.6, 3.3) 37 (15, 51) 54 50.4
Montana 2 2.9 (2.5, 3.3) 38 (13, 51) 41 58.0
North Dakota 2 2.9 (2.4, 3.4) 39 (10, 51) 26 54.4
Alabama 2 2.9 (2.7, 3.1) 40 (25, 50) 183 46.2
Oregon 2 2.8 (2.6, 3.1) 41 (26, 50) 157 57.3
Arizona 2 2.8 (2.7, 3.0) 42 (29, 49) 258 52.5
Iowa 7 2.8 (2.6, 3.0) 43 (26, 51) 113 55.7
Tennessee 2 2.8 (2.6, 2.9) 44 (32, 50) 236 49.4
West Virginia 2 2.8 (2.5, 3.1) 45 (22, 51) 72 51.6
Colorado 2 2.8 (2.6, 3.0) 46 (31, 51) 178 55.0
South Dakota 2 2.7 (2.3, 3.2) 47 (17, 51) 29 55.1
Nevada 2 2.7 (2.4, 2.9) 48 (31, 51) 100 52.0
Idaho 7 2.6 (2.3, 3.0) 49 (27, 51) 56 55.0
Utah 7 2.6 (2.3, 2.9) 50 (34, 51) 76 54.8
Wyoming 2 2.2 (1.7, 2.7) 51 (35, 51) 17 47.8
Puerto Rico 2 2.6 (2.4, 2.9) N/A 132 41.5

Notes:
Created by statecancerprofiles.cancer.gov on 03/22/2026 1:27 pm.

State Cancer Registries may provide more current or more local data.

Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.


† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2024 submission.

2 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission).

7 Source: SEER November 2024 submission.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.

Return to Top